Gülay Bulu

Gülay Bulu

Auto-generated profile, based on publicly available information

Gülay Bulu

Department of Obstetrics and Gynecology, Fethi Sekin City Hospital, 23000 Elazig, Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2025 in Medicine
Verified
Journal Article
Open access
ABAYKUT BULU
AYKUT BULU
GBGülay Bulu
Gülay Bulu
This study aimed to assess neutrophil-to-high-density lipoprotein cholesterol ratio (NHR) and other inflammatory and biochemical parameters as potential biomarkers for predicting gestational hypertension (GH) and preeclampsia (PE) in pregnant women. A total of 180 pregnant women were enrolled and divided into 3 groups: 58 with GH, 42 with PE, and 80 normotensive controls. Clinical, demographic, and laboratory data (inflammatory markers, lipid profiles, liver enzyme levels, and kidney function) were also collected. NHR and other biomarkers such as C-reactive protein (CRP) and white blood cell counts were compared across the groups. Statistical analyses, including univariate and multivariate regression, were conducted to identify significant predictors of GH and PE. The NHR was significantly higher in the GH (4.5 ± 1.1) and PE (5.2 ± 1.2) groups than in the normotensive controls (3.6 ± 1.1, P ˂ .001). Inflammatory markers, such as CRP, white blood cell count, and monocyte levels, were elevated in the GH and PE groups. In addition, the levels of glucose, creatinine, and liver enzymes were notably higher in the PE group. The NHR demonstrated a positive correlation with CRP levels. Regression analysis revealed that the NHR (P < .001), CRP (P = .002), and platelet count (P < .001) were independent predictors of GH and PE. The NHR may serve as an early inflammatory biomarker for predicting GH and PE. This finding suggests that NHR, along with other biomarkers, could be incorporated into clinical practice to improve the early identification and management of hypertensive disorders during pregnancy. Further prospective studies are needed to confirm these results and evaluate their clinical utility.

1 December 2020 in Perinatal Journal
Verified
Journal Article
Closed access
IBIbrahim Batmaz
Ibrahim Batmaz
SKSalih Burcin Kavak
Salih Burcin Kavak
EKEbru Celik Kavak
Ebru Celik Kavak
EGEvrim Gül
Evrim Gül
CŞCengiz şanlı
Cengiz şanlı
HKHasan Burak Keser
Hasan Burak Keser
Objective: To determine the maternal deaths and the factors affecting them in our city. Methods: The maternal deaths occurred in our city between January 2015 and June 2020 were reviewed retrospectively. The review was conducted by checking “Maternal Death Registry Forms” of the Provincial Directorate of Health. In cases where additional data related with the cause of death were required, the relatives of the cases, associated family practitioner, The Council of Forensic Medicine or local authorities were contacted. The data of the cases including age, gravida, parity, abortion, delivery type, week of gestation during delivery, period of death and maternal deaths due to direct, indirect and incidental causes were recorded. Based on total live births and maternal deaths within 6.5 years, maternal mortality rate was found as the maternal death number per 100,000 live births. Descriptive statistics were used for the statistical analysis of the data. Results: A total of 46.618 live births occurred between 2015 and 2020 in Elazığ. The number of maternal deaths due to direct and indirect causes is 7, and maternal mortality rate was found 15.01/100,000. Hypertensive diseases during pregnancy (n=3, 42.8%), pulmonary embolism (n=1, 14.3%) and cerebral thrombosis (n=1, 14.3%) were among the natural causes of maternal deaths. Indirect cause for maternal death was cardiac diseases (n=2, 28.6%). When they were categorized according to the Three Delays Model, there were 3 death cases in the first delay model and 2 death cases in the third delay model, but there was no maternal death in the second delay model. Conclusion: Maternal death is an significant public health issue which develops due to the generally preventable causes and maintains its importance. The factors contributing to death should be paid attention in order to decrease maternal death rates.

1 August 2020 in Perinatal Journal
Verified
Journal Article
Closed access
EKEbru Celik Kavak
Ebru Celik Kavak
SKSalih Burcin Kavak
Salih Burcin Kavak
CŞCengiz şanlı
Cengiz şanlı
GBGülay Bulu
Gülay Bulu
IBIbrahim Batmaz
Ibrahim Batmaz
HKHasan Burak Keser
Hasan Burak Keser
Objective To investigate the incidence and concomitant findings of persistent right umbilical vein (PRUV). Methods The study was conducted by retrospective review of the data of 1856 patients who admitted to the Clinic of Obstetrics and Gynecology of Fırat University between December 2018 and December 2019 for the gestational examination between 14 and 28 weeks of gestation. The obstetric characteristics of the patients such as age, number of pregnancy, abortion, parity and body mass index were recorded. The diagnosis of PRUV was established in the conditions where portal vein reaches to stomach abnormally (roughly, course towards stomach instead of parallel course), fetal gall bladder locates in the medial of umbilical vein or umbilical vein connects to right portal vein abnormally instead of left portal vein. In the cases diagnosed with PRUV, the isolated persistent right umbilical vein or its association with other anomalies was recorded. Ultrasonography findings (minor markers) were also recorded in these cases. Results During the study period, 1856 pregnant women were evaluated for gestational examination. Five cases were established with the diagnosis of PRUV. Accordingly, PRUV prevalence was 0.27%. The PRUV incidence in the study population was 1/370 in the study population. No chromosomal anomaly was found in PRUV cases, but one case had echogenic intracardiac focus, one case had echogenic intestine, and one case had short nasal bone. When organ systems were evaluated, renal cyst was found in one case. No additional finding was found in one case. Conclusion PRUV is the most common form among fetal venous system anomalies. If detected, fetal examination is required in terms of the anomalies that may accompany. Chromosome analysis is not necessary if it is isolated, and it should be evaluated as a variant of normal anatomy.

22 July 2026 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
GBGülay Bulu
Gülay Bulu
AAAlpaslan Akyol
Alpaslan Akyol
TKTuncay Kuloğlu
Tuncay Kuloğlu
CŞCengiz şanlı
Cengiz şanlı
Background:Ovarian torsion–detorsion injury induces ischemia–reperfusion–related oxidative stress, leading to ovarian tissue damage and impaired reproductive function. Asprosin has recently emerged as a metabolic hormone associated with oxidative stress and inflammation, but its role in ovarian ischemia–reperfusion injury remains unclear. This study aimed to evaluate the effects of N-acetylcysteine (NAC), a potent antioxidant, on reproductive capacity, as well as asprosin levels in a rat torsion–detorsion (T/D) model.Methods:35 Wistar albino rats were randomly assigned to five groups (n = 7 per group): Group I (Control), Group II (Sham), Group III (NAC), Group IV (T/D), and Group V (T/D + NAC). Ovarian tissue and blood samples were collected to assess asprosin immunoreactivity, serum asprosin levels, anti-Müllerian hormone (AMH) concentrations, and total oxidant status (TOS). Histopathological changes in ovarian tissue were evaluated using immunohistochemical techniques.Results:Serum TOS levels were higher in the T/D group than in the Control group (12.16 vs. 2.28, p = 0.016) and lower in the T/D + NAC group than in the T/D group (5.38 vs. 12.16, p = 0.032); however, neither difference remained statistically significant after Bonferroni correction. Serum asprosin levels were significantly lower in the NAC (0.81 vs. 1.39, p = 0.002) and T/D (0.47 vs. 1.39, p = 0.003) groups compared with the Control group, whereas the difference for the T/D + NAC group (0.96 vs. 1.39, p = 0.010) did not remain significant after correction. Serum asprosin levels were higher in the T/D + NAC group than in the T/D group (0.96 vs. 0.47, p = 0.008), although this difference did not persist after Bonferroni correction. In ovarian tissue, asprosin immunoreactivity was lower in the T/D group than in the Control group (p = 0.002) and higher in the T/D + NAC group than in the T/D group (p = 0.002). AMH levels did not differ significantly among groups (p > 0.05).Conclusion:NAC administration was associated with reduced oxidative stress and attenuated degenerative changes in ovarian T/D injury. Asprosin levels reflected ischemia–reperfusion–related alterations, decreasing after torsion and showing partial recovery following NAC treatment. These findings suggest that asprosin may represent a potential biomarker of metabolic and oxidative stress in ovarian ischemia–reperfusion injury; however, the underlying mechanistic relationship warrants further investigation.

11 March 2026 in Aile Hekimliği Ve Palyatif Bakım
Verified
Journal Article
Closed access
ABAYKUT BULU
AYKUT BULU
GBGülay Bulu
Gülay Bulu
Introduction: Gestational diabetes mellitus (GDM) is one of the most prevalent metabolic complications of pregnancy, posing significant risks to both maternal and neonatal health. Multiple maternal factors, including pre-pregnancy body mass index (BMI), gestational weight gain (GWG), height, and metabolic status, have been implicated in the development of macrosomia in GDM pregnancies. In recent years, novel inflammation-based hematological indices such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and neutrophil-to-HDL cholesterol ratio (NHR) have emerged as cost-effective biomarkers reflecting systemic inflammatory and metabolic alterations. However, their potential role in predicting macrosomia in GDM remains insufficiently explored. Thus, the purpose of our study was to asses the association between maternal risk factors, blood parameters, novel inflammatory markers, and macrosomia in patients with GDM. In addition, we aimed to develop and validate new predictive models for macrosomia in pregnancies complicated by GDM.Methods: A total of 200 patients diagnosed with GDM using a 75-gram oral glucose tolerance test (OGTT) between the 24th and 28th weeks of gestation were included in the study. Macrosomia was identified if birth weight exceeded 4,000 grams or the 90th percentile for gestational age. Patients were divided into two groups: 42 GDM patients with macrosomic offspring (GDM-M) and 158 GDM patients without macrosomia (GDM-N). Maternal characteristics, blood parameters, and novel inflammatory markers were compared between the GDM-M and GDM-N groups using statistical analyses. Point-biserial (Pearson-equivalent) correlation analysis was used to examine the relationships between various maternal, metabolic, and inflammatory parameters and macrosomia. Independent associations were then evaluated using multivariable logistic regression, with calibration and explained variance assessed. Discrimination was examined using receiver operating characteristic (ROC) curves for single predictors and a combined model; optimal cut-offs were derived by the Youden index.Results: GWG (p = 0.028), pre-pregnancy BMI (p = 0.023), maternal height (p < 0.001), fasting plasma glucose (FPG) (p < 0.001), glycated hemoglobin (HbA1c) (p < 0.001), triglyceride (TG) (p = 0.034), NLR (p = 0.012), and NHR (p = 0.018) levels were significantly higher in the GDM-M group than in the GDM-N group. In contrast, insulin (p < 0.001) and high-density lipoprotein cholesterol (HDL-C) (p = 0.022) levels were significantly lower in the GDM-M group compared with the GDM-N group. In adjusted analyses, higher pre-pregnancy BMI, maternal height, GWG, FPG, HbA1c, NLR, and NHR were associated with increased odds of macrosomia, whereas insulin and HDL-C were inversely associated. ROC analyses showed the highest single-marker area under curve (AUC)’s for maternal height (0.78; cut-off ≥162 cm), NHR (0.76; cut-off ≥3.2), and HbA1c (0.75; cut-off ≥7.4%), with NLR (0.74), GWG (0.73), FPG (0.72), and HDL-C (0.71; cut-off ≤42 mg/dL) performing similarly; the combined model achieved AUC 0.85 (95% CI 0.77–0.92), sensitivity 80.9%, specificity 78.5%, positive predictive value (PPV) 63.2%, and negative predictive value (NPV) 90.4%.Conclusion: There is an association between higher GWG, pre-pregnancy BMI, maternal height, FPG, and HbA1c levels, as well as lower insulin and HDL-C levels, and the occurrence of macrosomia in patients with GDM. These findings suggest that GWG, pre-pregnancy BMI, maternal height, FPG, HbA1c, insulin, HDL-C, NLR, and NHR may be useful in predicting macrosomia in pregnancies complicated by GDM. A compact multivariable model combining these routine measures demonstrated good discrimination with a high NPV, supporting potential use for early risk stratification.

2 November 2022 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
SKSalih Burcin Kavak
Salih Burcin Kavak
IBIbrahim Batmaz
Ibrahim Batmaz
AŞAhmet Şenocak
Ahmet Şenocak
MHMesut Ali HALİSÇELİK
Mesut Ali HALİSÇELİK
YGYeliz Gül
Yeliz Gül
EKEbru Celik Kavak
Ebru Celik Kavak
Özet Amaç: Serebral Ven Sinüs Trombozu (SVST) çok çeşitli ve nonspesifik semptomlarla kendini gösteren ve farklı etiyolojilere bağlı olarak ortaya çıkan klinik bir durumdur. Tanısı kolayca konulamayan nadir bir hastalıktır. Biz bu yazıda SVST gelişen olgularda, jinekolojik ve obstetrik nedenlerin araştırılmasını amaçladık. Gereç ve Yöntemler: Fırat Üniversitesi Tıp Fakültesi Hastanesi’ne Kasım 2010 ile Kasım 2020 tarihleri arasında nörolojik şikayetlerle başvuran, yapılan değerlendirmede SVST tanısı konulan olgular ile obstetrik/jinekolojik nedenlerle SVST gelişen kadınlar, retrospektif olarak incelendi. Kadınların başvuru şikâyetleri, nöroradyolojik bulguları ve uygulanan tedaviler kayıtlardan tespit edildi. Verilerin değerlendirmesinde tanımlayıcı istatistik kullanıldı. Bulgular: Çalışmanın yapıldığı dönemde 166 olguya SVST tanısı konuldu. Olguların 105’i kadın (%63.2) ve 61’i erkek (%36.8) idi. On beş olguda (% 9) obstetrik ve jinekolojik nedenlere sekonder SVST geliştiği tespit edildi. En sık semptom baş ağrısı (%80) ve en sık bulgu papil ödemi (%20) ile birlikte hemiparezi (%13.3) ve hemipleji (%6.7) olarak tespit edildi. Çalışmaya dâhil edilen altı olgu (%40) puerperal dönemde idi. Bunlardan iki olgu (%13.3) vajinal yolla, dört olgu (%26.7) ise sezaryenle doğum yapmıştı. Olgulardan beş tanesi (%33.3) gebe idi. Gebelerin tamamı gebeliğin 3. trimesterinde bulunuyordu. Bir olguda (%6.7) mastoidit geliştiği ve 4 ay öncesinde vajinal yolla doğum yaptığı tespit edildi. Bir olgunun puerperal dönemde olduğu ve eşlik eden sinüzit enfeksiyonu bulunduğu (%6.7), ayrıca aile öyküsünde postpartum derin ven trombozu varlığı tespit edildi. İki olgunun (%13.3) kombine oral kontraseptif (OKS) kullandığı, bunlardan birinde MTHFR homozigot mutasyon varlığı ve homosistein yüksekliği olduğu tespit edildi. Olguların tamamı değerlendirildiğinde 7 olguda (%4.2) kalıtsal trombofili tanısı mevcuttu. Sonuç: SVST olgularında gebelik, puerperal dönem ve OKS kullanımı başta olmak üzere, obstetrik ve jinekolojik nedenler %10’a yakın yer tutar ve değerlendirme sırasında göz önünde bulundurulmalıdır